Mesenchymal stem cells and oncolytic viruses: joining forces against cancer
J Immunother Cancer. 2021 Feb;9(2):e001684. doi: 10.1136/jitc-2020-001684.ABSTRACTThe…
The Tumor Microenvironment in Liver Metastases from Colorectal Carcinoma in the Context of the Histologic Growth Patterns
Int J Mol Sci. 2021 Feb 3;22(4):1544. doi: 10.3390/ijms22041544.ABSTRACTColorectal…
Evolving Status of Clinical Immunotherapy with Oncolytic Adenovirus
Clin Cancer Res. 2021 Jun 1;27(11):2979-2988. doi: 10.1158/1078-0432.CCR-20-1565.…
RNF168 regulates R-loop resolution and genomic stability in BRCA1/2-deficient tumors
J Clin Invest. 2021 Feb 1;131(3):e140105. doi: 10.1172/JCI140105.ABSTRACTGermline…
Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced-stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high-risk patients from the ECHELON-1 study
Hematol Oncol. 2021 Apr;39(2):185-195. doi: 10.1002/hon.2838.…
A modular master regulator landscape controls cancer transcriptional identity
Cell. 2021 Jan 21;184(2):334-351.e20. doi: 10.1016/j.cell.2020.11.045.…
PEPCK-M recoups tumor cell anabolic potential in a PKC-ζ-dependent manner
Cancer Metab. 2021 Jan 7;9(1):1. doi: 10.1186/s40170-020-00236-3.ABSTRACTBACKGROUND:…
Nivolumab Plus Ipilimumab for Treatment-Naïve Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402)
J Clin Oncol. 2021 Feb 20;39(6):586-598. doi: 10.1200/JCO.20.00550.…
Interplay between UNG and AID governs intratumoral heterogeneity in mature B cell lymphoma
PLoS Genet. 2020 Dec 23;16(12):e1008960. doi: 10.1371/journal.pgen.1008960.…
Progesterone receptor isoform-dependent cross-talk between prolactin and fatty acid synthase in breast cancer
Aging (Albany NY). 2020 Dec 10;12(24):24671-24692. doi: 10.18632/aging.202289.…
Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study
Lancet Oncol. 2021 Jan;22(1):142-154. doi: 10.1016/S1470-2045(20)30680-X.…
FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma
Clin Cancer Res. 2021 Mar 1;27(5):1491-1504. doi: 10.1158/1078-0432.CCR-20-0232.…
